Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.260
+0.040 (1.80%)
At close: Oct 6, 2025, 4:00 PM EDT
2.270
+0.010 (0.44%)
Pre-market: Oct 7, 2025, 5:26 AM EDT

Annovis Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
446919211014252
Upgrade
Market Cap Growth
-60.95%-63.84%75.03%-23.01%174.06%-
Upgrade
Enterprise Value
2757186789543
Upgrade
Last Close Price
2.265.0318.7013.4317.587.54
Upgrade
PB Ratio
2.407.46-24.763.873.206.89
Upgrade
P/TBV Ratio
2.407.46-3.873.206.89
Upgrade
Quick Ratio
6.112.721.353.6930.3313.96
Upgrade
Current Ratio
7.653.592.394.6830.5414.04
Upgrade
Return on Equity (ROE)
-365.03%-3159.09%-546.40%-69.57%-55.68%-180.82%
Upgrade
Return on Assets (ROA)
-111.68%-138.26%-121.77%-38.88%-33.58%-89.86%
Upgrade
Return on Capital (ROIC)
-178.51%-2143.41%-273.63%-43.79%-34.92%-126.89%
Upgrade
Earnings Yield
-68.71%-35.43%-29.29%-23.10%-10.17%-10.51%
Upgrade
Buyback Yield / Dilution
-55.91%-35.60%-10.55%-7.03%-20.88%-2132.36%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q